New Jersey 2024-2025 Regular Session

New Jersey Senate Bill S322

Introduced
1/9/24  
Introduced
1/13/26  
Refer
1/9/24  

Caption

"Improved Suicide Prevention, Response, and Treatment Act."

Impact

If passed, SB 322 would amend existing laws surrounding controlled substances, delineating tianeptine's legal status and usage guidelines. The bill aligns with broader efforts to combat the opioid crisis by increasing oversight of substances that can lead to addiction and presenting significant health hazards. It also sets a precedent for managing new psychoactive substances that emerge on the market, as legislators recognize shifting drug trends and their implications for public health.

Summary

Senate Bill 322 aims to classify tianeptine, a substance commonly associated with opioid-like effects and rising abuse trends, as a Schedule II controlled dangerous substance in New Jersey. This designation reflects concerns over its high potential for abuse and the severe health risks associated with its misuse, including respiratory depression and death. By regulating tianeptine under stricter controls, the legislation intends to curtail its presence in the illicit drug market where it has gained notoriety as 'gas station heroin.'

Sentiment

The sentiment surrounding SB 322 appears to be overwhelmingly supportive among public health advocates and lawmakers concerned about addiction. Proponents argue that reclassifying tianeptine is a necessary step toward safeguarding communities against the dangers of substance abuse and reducing the healthcare burden associated with opioid overdoses. However, discussions might also surface about the balance between necessary regulation and individuals' access to legitimate medical treatment options, raising questions about the implications of stringent controls on therapeutic uses.

Contention

A potential point of contention might arise concerning the medical applicability of tianeptine. While the bill focuses on curtailing abuse, there are advocates who believe it has legitimate uses that could be compromised by its Schedule II classification. Critics of heavy regulation may argue that this could limit availability for patients benefiting from its use. The continuing debate will likely revolve around how best to manage such substances without sacrificing public health and safety.

Companion Bills

NJ A1536

Same As "Improved Suicide Prevention, Response, and Treatment Act."

NJ S143

Carry Over "Improved Suicide Prevention, Response, and Treatment Act."

NJ A3750

Carry Over "Improved Suicide Prevention, Response, and Treatment Act."

NJ S729

Carry Over Requires State employees to be trained in disability law and etiquette.

NJ A4814

Carry Over Removes expected family contribution from calculation of financial need under circumstances in which public institutions of higher education may reduce student's institutional financial aid.

Previously Filed As

NJ S322

Establishes tianeptine as Schedule II controlled dangerous substance.

NJ A2653

Requires reporting of first responder suicides to DOH.

NJ S3597

Requires boards of education to adopt suicide prevention policies and DOE to establish model suicide prevention policy.

NJ A4663

Requires boards of education to adopt suicide prevention policies and DOE to establish model suicide prevention policy.

NJ A1938

Establishes one New Jersey Suicide Prevention Advisory Council in DOH.

NJ S1865

Adds illicit fentanyls to Schedule I in the "New Jersey Controlled Dangerous Substances Act."

NJ HB1190

MS First Responder PTSD and Suicide Prevention Task Force; create.

NJ A3278

Requires reporting of suicide attempts made by first responders.

NJ S4135

Establishes one New Jersey Suicide Prevention Advisory Council in DOH.

NJ S1596

Establishes Veterans Suicide Prevention Commission.

Similar Bills

NJ S322

Establishes tianeptine as Schedule II controlled dangerous substance.

TX SB1868

Relating to adding certain substances to the Texas Controlled Substances Act and regulating kratom and kratom products; increasing civil penalties; creating criminal offenses; increasing a criminal penalty.

PA SB946

Further providing for schedules of controlled substances and providing for tianeptine-related adverse health events.

CA AB634

Tianeptine.

US HB3520

STAND Against Emerging Opioids Act Scheduling Tianeptine and Analogues Now to Defend Against Emerging Opioids Act

DE HB21

An Act To Amend Title 16 Of The Delaware Code Relating To Tianeptine.

NE LB475

Classify tianeptine as a controlled substance

SC H5485

Controlled Substances